Category Archives: HIV/AIDS

Research to combat dual epidemics: A conversation with CDC’s Jordan Tappero

By on .

Science Speaks is delving into the global HIV and tuberculosis research and development efforts at the U.S. Centers for Disease Control and Prevention (CDC) with a series of interviews with staffers who are key to the success of their programs. For the fourth interview in the series, we spoke with Jordan W. Tappero, MD, MPH, who […]

Clinton testimony short on details about global health budget requests

By on .

  U.S. Secretary of State Hillary Clinton testified Tuesday in front of the Senate State and Foreign Operations Appropriations Subcommittee in defense of President Obama’s proposal for national security and foreign policy priorities in the fiscal year (FY) 2013 international affairs budget, including U.S. investments in global health. “Through the Global Health Initiative, we are […]

Community group cautions WHO on communication of its guidance on hormonal contraceptives and HIV

By on .

The International Community of Women Living with HIV (ICW) expressed concern Monday over the World Health Organization’s (WHO’s) Technical Statement on Hormonal Contraceptives and HIV and its accompanying press release. WHO released the statement last week – concluding that women living with HIV or at high risk of HIV can safely continue to use hormonal […]

Why global health activists are fired up about Novartis

By on .

The following is a guest blog post by Professor Brook Baker of Northeastern University’s School of Law, Program on Human Rights and the Global Economy, describing and commenting on pharmaceutical company Novartis’s court challenge to India’s strict standards of patenting medicine — standards that have increased access to affordable generic medications worldwide —  and the Novartis […]

Innovative programming to combat HIV, TB and cholera: A conversation with CDC’s John Vertefeuille

By on .

In this third post in a series of conversations with officials at the U.S. Centers for Disease Control and Prevention (CDC) discussing the CDC’s role in global HIV and tuberculosis research and development, Science Speaks sat down with John Vertefeuille, PhD – the country director for CDC in Haiti. There he leads a team of 55 and […]

Protecting and Promoting the Sexual Rights of Women Living with HIV

By on .

On Tuesday the U.S. Positive Women’s Network (PWN) hosted a webinar to discuss HIV-positive women’s sexual rights and to commemorate Valentine’s Day as a day to uphold the rights of HIV-positive women to have safe and satisfying sexual lives.  According to a fact sheet released by PWN, “An expression of love for women living with […]

Expert panel strategizes to repeal the federal ban on funding for syringe exchange

By on .

(The following guest blog post is by Yale University senior Helen Jack) “The federal ban on needle exchange funding is institutional stigma,” said Allan Clear, executive director of the Harm Reduction Coalition, to an audience of nearly 100 students and community members at a Yale University auditorium Wednesday night. By reinstating the federal ban on funding for syringe exchange programs, Clear said the government sends the wrong message…

NIH launches program to ease access to technologies for humanitarian efforts

By on .

At a White House briefing Wednesday morning on science, technology and innovation for global development, head of the National Institutes of Health (NIH) Dr. Francis Collins announced a new effort to increase access to innovative technologies for those working to provide broad global access to technologies, products and services…

HIV docs tell a powerful tale of combination prevention

By on .

“This is an extraordinary moment in the AIDS epidemic – we finally have the tools to turn the tide,” said Diane Havlir, MD, of the University of California San Francisco, speaking to the arsenal of HIV prevention interventions the AIDS community now has at its disposal to combat new infections worldwide. She spoke alongside a […]

NIAID announces funding ops for HIV Clinical Trial Networks, including TB and Hepatitis

By on .

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) and the leading funder of AIDS research, issued long-awaited funding announcements to create leadership groups for clinical research networks in HIV that will also address tuberculosis (TB) and hepatitis—leading co-morbidities in persons with HIV infection. Requests for applications […]